CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 7250 result(s)

Visual Examination Frequency for People Taking Ethambutol for Tuberculosis

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Summary with Critical Appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Genetic Carrier Screening for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies, and Spinal Muscular Atrophy: A Qualitative Rapid Review

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Summary with Critical Appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Switching from Reference to Biosimilar Filgrastim in Pediatric Patients

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Summary of Abstracts

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Direct to Patient Virtual Visits

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Horizon Scan - Bulletin

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Autologous Hematopoietic Cell Transplant (AHSCT) for People with Multiple Sclerosis

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Horizon Scan - Bulletin

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Prevention of Tuberculosis Reactivation

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Summary with Critical Appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Home COVID test - Lucira

Last Updated: May 14, 2021
Result type: Projects in Progress

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Interventions for Violence Reduction towards Health Care Workers in the Emergency Department

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Summary with Critical Appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Low Dose Five Year Intrauterine Devices for Treatment of Endometriosis

Last Updated: May 14, 2021
Result type: Projects in Progress
Report Type: Reference List

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

mecasermin (Increlex)

Last Updated: May 14, 2021
Result type: Reports
Product Line: Reimbursement Review
Generic Name: mecasermin
Indications: Increlex (mecasermin) is indicated for the treatment of growth failure in children and adolescents from 2 to 18 years with confirmed severe primary insulin-like growth factor-1 deficiency (SPIGFD). SPIGFD is defined by: • Height standard deviation score ≤ –3.0 and; • Basal IGF-1 levels below the 2.5th percentile for age and gender and; • GH sufficiency. • Exclusion of secondary forms of IGF-1 deficiency, such as malnutrition, hypopituitarism, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids. SPIGFD includes patients with mutations in the GH receptor (GHR) gene/Laron’s syndrome, post-GHR signaling pathway, and IGF-1 gene defects; they are not GH deficient, and therefore, they cannot be expected to respond adequately to exogenous GH treatment.

  • Brand Name: Increlex
  • Manufacturer: Ipsen Biopharmaceuticals Canada, Inc.
  • Project Number: SR0692-000
  • Project Status: Pending
  • Submission Type: Initial